Jeremy Barton, M.D.
About Jeremy Barton, M.D.
Jeremy Barton, M.D. - Acting Chief Medical Officer
Jeremy Barton, M.D., holds the position of Acting Chief Medical Officer. With over 30 years of global oncology drug development experience, he has established himself as a leader in the field. His extensive experience encompasses various roles in prominent pharmaceutical and biotechnology companies.
Jeremy Barton, M.D. - Professional Background
Jeremy Barton's professional background includes significant roles in several leading healthcare organizations. Before his current role, he served as the Chief Medical Officer at Biogen, eFFECTOR Therapeutics, and Mirati Therapeutics. He also held the position of Head of Oncology, Biotechnology Clinical Development at Pfizer. His career spans across numerous high-impact roles, underlining his deep expertise in oncology drug development.
Jeremy Barton, M.D. - Education and Certification
Jeremy Barton earned an M.S. in physiological sciences from Oxford University and an M.D. from University College Hospital Medical School in London. He is board-certified in internal medicine and clinical oncology. Additionally, he is a member of the Royal College of Physicians in the United Kingdom, a fellow of the Royal College of Radiologists, and a member of the Faculty of Pharmaceutical Medicine.
Jeremy Barton, M.D. - Clinical Training and Practice
Jeremy Barton's clinical training includes internal medicine and clinical oncology in the United Kingdom. He practiced for 11 years in the National Health Service (NHS), which provided a solid foundation for his expertise in clinical medicine and oncology. His hands-on experience in the NHS has been instrumental in his subsequent roles in drug development and clinical research.
Jeremy Barton, M.D. - Memberships and Fellowships
Jeremy Barton is an esteemed member of several professional organizations. He is a member of the Royal College of Physicians in the United Kingdom, a fellow of the Royal College of Radiologists, and a member of the Faculty of Pharmaceutical Medicine. These memberships and fellowships reflect his ongoing commitment to professional development and his recognized expertise in the medical field.